Parameter | Test group | Reference group | p |
---|---|---|---|
Number of patients | 70 | 76 | na |
Age in years; (mean ± SD) | 56.46 ± 5.80 | 56.83 ± 5.57 | ns |
Weight; (kg) (mean ± SD) | 63.82 ± 9.33 | 65.72 ± 11.94 | ns |
Male: Female | 48:22 | 52:24 | ns |
Patients with type II diabetes; %, (n/N) | 41.43, (29/70) | 34.21, (26/76) | ns |
Patients with history of angina; %, (n/N) | 5.71, (4/70) | 2.63, (2/76) | ns |
Patients on captopril; %, (n/N) | 32.85Â % (23/70) | 30.26Â % (23/76) | ns |
Patients on enalapril; %, (n/N) | 31.42Â % (22/70) | 31.57Â % (24/76) | ns |
Patients on losartan;%, (n/N) | 34.28Â % (24/70) | 38.15Â % (29/76) | ns |
Patients on atenolol; %, (n/N) | 67.14Â % (47/70) | 63.15Â % (48/76) | ns |
Patients on carvedilol; %, (n/N) | 14.28Â % (10/70) | 25Â % (19/76) | ns |
Patients on metoprolol;%, (n/N) | 11.42Â % (8/70) | 7.89Â % (6/76) | ns |
Patients on bisoprolol; %, (n/N) | 4.28Â % (3/70) | 2.63Â % (2/76) | ns |
Hb (mean ± SD) | 13.61 ± 1.73 | 13.57 ± 1.55 | ns |
Total WBC count (mean ± SD) | 7.67 ± 1.95 | 7.52 ± 1.91 | ns |
SGOT (mean ± SD) | 32.94 ± 13.45 | 35.41 ± 19.20 | ns |
SGPT (mean ± SD) | 35.86 ± 18.29 | 34.95 ± 20.79 | ns |
LDL (mean ± SD) | 82.38 ± 26.83 | 77.26 ± 31.24 | ns |
HDL (mean ± SD) | 40.24 ± 9.18 | 38.26 ± 8.19 | ns |
VLDL (mean ± SD) | 29.29 ± 11.70 | 34.13 ± 22.02 | ns |
Total cholesterol (mean ± SD) | 152.17 ± 33.59 | 150.28 ± 39.42 | ns |
Triglycerides (mean ± SD) | 146.24 ± 58.34 | 158.25 ± 76.50 | ns |
Fasting blood glucose (mean ± SD) | 116.57 ± 43.35 | 120.09 ± 52.84 | ns |
Serum creatinine (mean ± SD) | 0.90 ± 0.31 | 0.87 ± 0.25 | ns |